Ninety One North America’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ninety One North America’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24,883	Closed	-$902K	–	108
2016 Q4	$902K	Sell	24,883 -217,766	-90%	-$8.69M	0.14%	97
2016 Q3	$11.2M	Buy	242,649 +14,553	+6%	+$759K	1.5%	14
2016 Q2	$11.5M	Buy	228,096 +63,193	+38%	+$3.36M	1.69%	9
2016 Q1	$8.82M	Buy	164,903 +118,425	+255%	+$6.95M	1.47%	29
2015 Q4	$3.05M	Buy	46,478 +31,012	+201%	+$1.92M	0.54%	58
2015 Q3	$873K	Buy	15,466 +3,916	+34%	+$254K	0.22%	75
2015 Q2	$683K	Hold	11,550	–	–	0.22%	74
2015 Q1	$720K	Sell	11,550 -2,580	-18%	-$150K	0.22%	73
2014 Q4	$813K	Buy	+14,130	New	+$787K	0.24%	68

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ninety One North America's TEVA Position: Q1 2017 in Review

Ninety One North America sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 24,883 shares — an estimated $902K sold.

Ninety One North America first reported a position in TEVA in Q4 2014 and held it in 9 quarters. The position peaked at $11.5M in Q2 2016. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

Ninety One North America reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
Ninety One North America sold 24,883 Teva Pharmaceutical Industries Limited shares in Q1 2017, an estimated $902K.
Ninety One North America first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 9 quarters.
Ninety One North America's Teva Pharmaceutical Industries Limited position peaked at $11.5M in Q2 2016.
688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Ninety One North America's 13F filing for Q1 2017, filed 12 May 2017.